Does HUSKY Health cover GLP-1s for weight loss?

HUSKY Health covers GLP-1s only for heart disease, MASH, sleep apnea or type 2 diabetes, not for weight loss alone

Not for weight loss alone
By Iacob Pastina, Independent Researcher & Publisher
Updated · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

If you are an adult and weight loss is your only reason, HUSKY Health does not cover a GLP-1.

If one of the uses below applies to you, your prescriber can ask HUSKY Health to cover that drug. Read the rule and its criteria.

  • Nofor adult weight loss alone
  • July 1, 2025when the rules we checked took effect
  • $49/molowest cash price in Connecticut, at Embody

Which drugs HUSKY Health covers, and for what:

Wegovy
Heart disease or MASH
Zepbound
Sleep apnea
Ozempic, Mounjaro, Trulicity
Type 2 diabetes
Orlistat, phentermine
Weight loss; these are older pills, not GLP-1s

We checked 6 official documents on October 15, 2026. This is information, not medical advice or a benefit decision.

What does a GLP-1 cost without insurance in Connecticut?

7 programs that serve Connecticut publish a complete monthly price, from $49 at Embody to $299 at Willow.

Programs that serve Connecticut, lowest monthly price first

Some programs are affiliate partners, and we may earn a commission if you join through our link. Payment never moves a row. How we rank

3 more programs serve Connecticut without one complete monthly price: Collective, Maximus and Wellorithm. Compare their terms in the price index.

We left out 30 programs whose service-area list has a caveat for Connecticut or is incomplete, so confirm your address at intake.

A program that serves Connecticut still decides whether to prescribe. Before enrolling, confirm whether it accepts your Medicaid plan and whether your prescribed treatment is covered. The advertised cash prices are not insurance copays. Most listed programs sell compounded semaglutide or tirzepatide, which is not FDA-approved. Check a compounded provider before you pay.

  • Lowest in Connecticut$49/moAt Embody, the lowest complete monthly price among programs that serve Connecticut.
  • National median$99/moThe median advertised recurring price across 9 compounded programs we track, a national benchmark, not a measured Connecticut average.
  • National range$49 to $299The lowest and highest advertised recurring prices in that group.

What does HUSKY Health cover for GLP-1s?

Here is our summary of the HUSKY Health rules we checked, with their criteria and limits.

HUSKY Health covers GLP-1 medicines only for specific medical uses such as heart disease, MASH, sleep apnea or type 2 diabetes, not for weight loss alone, under Connecticut Medical Assistance Program pharmacy bulletins in effect since 2025 and its current indication-specific authorization forms. Since July 1, 2025, HUSKY A, B, C and D have covered two older weight-loss pills, orlistat and phentermine, through the pharmacy benefit. For diabetes GLP-1 drugs such as Ozempic, Mounjaro and Trulicity, your pharmacy claim must carry a type 2 diabetes diagnosis. HUSKY Health uses separate prior authorization forms for Wegovy to lower cardiovascular risk if you are an adult with established heart disease, for Wegovy if you have MASH, a fatty liver disease, and for Zepbound if you are an adult with moderate to severe obstructive sleep apnea who keeps using a CPAP-type device unless your doctor rules it out. Your prescriber must renew an approval each year, and HUSKY Health still decides each request. We could not list every 2026 bulletin, so ask the Connecticut Medical Assistance Program or your prescriber to confirm the current form for your exact drug and diagnosis.

HUSKY D is the HUSKY coverage group for adults without minor children. Provider Bulletin 2025-31 names HUSKY A, B, C and D together when it sets out that pharmacy coverage, so the same bulletin applies to you on HUSKY D as to the other groups.

A drug on the preferred list is not covered for every use, so check the rule for yours. A weight-loss exclusion leaves diabetes and other medical requests to their own rules.

We checked Connecticut Provider Bulletin 2025-31, June 2025: GLP-1 diagnosis requirement and orlistat and phentermine coverage from July 1, 2025 on October 15, 2026.

We checked Connecticut Provider Bulletin 2024-66, December 2024: type 2 diabetes diagnosis requirement for GLP-1 claims on October 15, 2026.

We checked HUSKY Wegovy cardiovascular-risk authorization form on October 15, 2026.

We checked HUSKY Wegovy MASH authorization form on October 15, 2026.

We checked Connecticut Provider Bulletin 2025-32, June 2025: Zepbound for obstructive sleep apnea from July 1, 2025 on October 15, 2026.

We checked HUSKY Zepbound sleep-apnea authorization form on October 15, 2026.

We read the HUSKY Health program site and Provider Bulletin 2025-31 again on October 16, 2026.

What should you ask HUSKY Health before you pay?

Call your Medicaid plan, Medicare drug plan or private insurer with these questions, and keep the reference number for each call.

Before you pay cash, confirm:

  • Whether your plan covers your exact drug, form and dose for your diagnosis and age.
  • Whether you are in fee-for-service or a managed-care plan, and who handles your prior authorization.
  • Which records your prescriber must send with the request.
  • Which pharmacy can fill it, and your drug copay apart from any visit, lab or membership fees.
  • Whether paying cash affects your benefits.
  • If the plan says no, the reason in writing, how to ask for a review and the deadline on the notice.

An “insurance accepted” badge does not tell you your benefit, so ask your plan how its review works.

What paperwork does prior authorization need?

Your prescriber sends HUSKY Health a request with the records that show you meet the rule for your drug and diagnosis, and HUSKY Health decides.

What HUSKY Health's own criteria ask for, from the documents we read:

  • The form for your indication: the Wegovy cardiovascular-risk form, the Wegovy MASH form or the Zepbound sleep-apnea form.
  • For Zepbound, that you keep using a CPAP-type device unless your doctor rules it out.
  • A renewal each year.

What your prescriber usually sends:

  • The condition the request relies on, as HUSKY Health names it: Wegovy for heart disease or MASH; Zepbound for sleep apnea; Ozempic, Mounjaro, Trulicity for type 2 diabetes; Orlistat, phentermine for weight loss; these are older pills, not GLP-1s.
  • Your BMI, with the height and weight it comes from and the date your prescriber measured them.
  • Chart notes that document the condition, such as a sleep study for sleep apnea or the liver scarring stage for MASH, where the rule asks for them.
  • The exact drug, form and dose your prescriber requests, and whether you have diabetes, because some routes exclude it.
  • What you have tried already: diet and activity changes, and any earlier medicine the rule asks about.
  • For a renewal, your weight, refill and treatment records since the first approval.

Your prescriber works from these HUSKY Health documents:

Your prescriber's office files the request; you cannot file it yourself. If HUSKY Health says no, ask for the reason in writing, because the notice tells you how to ask for a review and by when.

How does Medicare cover GLP-1s in Connecticut?

Medicare's GLP-1 Bridge follows federal rules in every state, so HUSKY Health's policy does not decide your Medicare benefit.

GLP-1 Bridge
If your weight-management prescription qualifies and Humana, CMS's central processor, approves it, your drug copay is $50 a month. That copay does not count toward your Part D out-of-pocket spending.
Regular Part D
Ask your drug plan whether it covers your exact medicine for your diagnosis. A plan denial does not by itself make you eligible for the Bridge. Our Medicare GLP-1 coverage guide goes drug by drug.

We checked CMS's Bridge guidance for Part D plans on September 26, 2026.

Who can help with coverage in Connecticut?

Two free official services can help you, and we earn no commission from either.

Medicaid
If a managed-care plan runs your drug benefit, call the member-services number on your card for its criteria and a written decision. Connecticut Medicaid
Medicare counseling
Your State Health Insurance Assistance Program (SHIP) explains a plan or notice for free. It does not approve a prescription. Connecticut SHIP counseling

Questions about GLP-1 access in Connecticut

Does HUSKY Health cover GLP-1 medication for weight loss?

HUSKY Health covers GLP-1 medicines only for specific medical uses such as heart disease, MASH, sleep apnea or type 2 diabetes, not for weight loss alone, under Connecticut Medical Assistance Program pharmacy bulletins in effect since 2025 and its current indication-specific authorization forms.

Since July 1, 2025, HUSKY A, B, C and D have covered two older weight-loss pills, orlistat and phentermine, through the pharmacy benefit. For diabetes GLP-1 drugs such as Ozempic, Mounjaro and Trulicity, your pharmacy claim must carry a type 2 diabetes diagnosis. HUSKY Health uses separate prior authorization forms for Wegovy to lower cardiovascular risk if you are an adult with established heart disease, for Wegovy if you have MASH, a fatty liver disease, and for Zepbound if you are an adult with moderate to severe obstructive sleep apnea who keeps using a CPAP-type device unless your doctor rules it out. Your prescriber must renew an approval each year, and HUSKY Health still decides each request. We could not list every 2026 bulletin, so ask the Connecticut Medical Assistance Program or your prescriber to confirm the current form for your exact drug and diagnosis. Before you pay, confirm your exact drug, your diagnosis, any age rules and your plan's authorization steps.

Is Medicare GLP-1 coverage different in Connecticut?

Yes.

Medicare's GLP-1 Bridge follows federal eligibility rules in every state, not HUSKY Health's policy. Your ordinary Part D coverage depends on your prescription and your drug plan, and the Bridge runs its own eligibility and authorization review.

Can I get GLP-1 medication delivered in Connecticut?

Yes, from 10 online programs that publish a service area including Connecticut.

At intake, confirm your address, the exact medication and any pharmacy limits, because a state listing does not guarantee you a prescription or a delivery date.

How much does GLP-1 treatment cost in Connecticut?

Among programs that serve Connecticut, the lowest complete monthly price we found is $49 at Embody.

Across the 9 compounded programs we track nationally, the median advertised recurring price is $99/mo, from $49 to $299. That national figure is not a measured Connecticut average, insurance copay or quote for your dose.

Featured Partners

Affiliate partners we feature. We may earn a commission.

Embody

Embody illustration of a compounded semaglutide injection vial
from $49/mo·Compounded

Collective

Collective provider illustration of compounded semaglutide injection vial
from $59/mo + $199/year membership after 21 days·Compounded

Gala

Current program options·Brand & Compounded

Check the medication, commitment and total price for your selected plan.

Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. Published scores have different evidence limits and do not establish better care. See the program comparison and scoring limitations.